Cited by 523Histone Deacetylase Inhibitors ResearchUbiquitin and proteasome pathwaysGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

Open access

Krämer, Oliver H., Zhu, Ping, Ostendorff, Heather P., Golebiewski, Martin, Tiefenbach, Jens, Peters, Marvin A., Brill, Boris, Groner, Bernd, Bach, Ingolf, Heinzel, Thorsten, Göttlicher, Martin·2003·The EMBO Journal

DOI 10.1093/emboj/cdg315PMC PMC165640

Open this paper in CoChat — free account

Abstract

Histone-modifying enzymes play essential roles in physiological and aberrant gene regulation. Since histone deacetylases (HDACs) are promising targets of cancer therapy, it is important to understand the mechanisms of HDAC regulation. Selective modulators of HDAC isoenzymes could serve as efficient and well-tolerated drugs. We show that HDAC2 undergoes basal turnover by the ubiquitin-proteasome pathway. Valproic acid (VPA), in addition to selectively inhibiting the catalytic activity of class I HDACs, induces proteasomal degradation of HDAC2, in contrast to other inhibitors such as trichostatin A (TSA). Basal and VPA-induced HDAC2 turnover critically depend on the E2 ubiquitin conjugase Ubc8 and the E3 ubiquitin ligase RLIM. Ubc8 gene expression is induced by both VPA and TSA, whereas only TSA simultaneously reduces RLIM protein levels and therefore fails to induce HDAC2 degradation. Thus, poly-ubiquitination and proteasomal degradation provide an isoenzyme-selective mechanism for downregulation of HDAC2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/emboj/cdg315

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,296
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,544
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Protein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,227
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W., Brard, G., Ngo, S. D., Davie, J., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,210

Show all 41 references

Sorted by citations

Items 101–200 of 522

The ubiquitin ligase Rnf6 regulates local LIM kinase 1 levels in axonal growth conesPreprint
Tursun, B., Schlüter, A., Peters, M. A., Viehweger, B., Ostendorff, H. P., Soosairajah, J., Drung, A., Bossenz, M., Johnsen, S. A., Schweizer, M., et al. (2005) · Genes & Development · doi:10.1101/gad.1340605 · Cited by 119
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: Where do we stand?
Whittle, N., & Singewald, N. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130233 · Cited by 117
Hydralazine target: From blood vessels to the epigenome
Arce, C., Segura-Pacheco, B. A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Candelaria, M., & Dueñnas-Gonzalez, A. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-10 · Cited by 118
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L. I., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 118
Chemopreventive Agent 3,3′-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases
Li, Y., Li, X., & Guo, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1924 · Cited by 115
Plant-derived epigenetic modulators for cancer treatment and prevention
Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.03.009 · Cited by 117
Sodium valproate: an old drug with new roles
Nalivaeva, N. N., Belyaev, N. D., & Turner, A. J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.002 · Cited by 115
Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis
Jurkin, J., Zupkovitz, G., Lagger, S., Grausenburger, R., Hagelkrüys, A., Kenner, L., & Seiser, C. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14712 · Cited by 112
Chronic Administration of Valproic Acid Inhibits Activation of Mouse Hepatic Stellate Cells in Vitro and in Vivo
Mannaerts, I., Nuytten, N., Rogiers, V., Vanderkerken, K., van Grunsven, L. A., & Geerts, A. E. (2009) · Hepatology · doi:10.1002/hep.23334 · Cited by 112
HDAC inhibitors in experimental liver and kidney fibrosis
Beneden, K. V., Mannaerts, I., Pauwels, M., Branden, C. V. D., & van Grunsven, L. A. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-1 · Cited by 110
Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway
Go, H. S., Kim, K. C., Choi, C. S., Jeon, S. J., Kwon, K. J., Han, S., Lee, J., Cheong, J. H., Ryu, J. H., Kim, C., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.028 · Cited by 110
Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts
Ji, P., Yeh, V., Ramírez, T., Murata‐Hori, M., & Lodish, H. F. (2010) · Haematologica · doi:10.3324/haematol.2010.029827 · Cited by 108
Histone deacetylases: salesmen and customers in the post‐translational modification market
Brandl, A., Heinzel, T., & Krämer, O. H. (2009) · Biology of the Cell · doi:10.1042/bc20080158 · Cited by 109
Inhibition of Histone Deacetylase Activity by Valproic Acid Blocks Adipogenesis
Lagace, D. C., & Nachtigal, M. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312795200 · Cited by 108
Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer
Botrugno, O. A., Santoro, F., & Minucci, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.027 · Cited by 105
Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis
Zeitelhofer, M., Adzemovic, M. Z., Gómez-Cabrero, D., Bergman, P., Hochmeister, S., N’diaye, M., Paulson, A., Ruhrmann, S., Almgren, M., Tegner, J. N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615783114 · Cited by 112
Regulation of Mammalian Epithelial Differentiation and Intestine Development by Class I Histone Deacetylases
Tou, L., Liu, Q., & Shivdasani, R. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3132-3139.2004 · Cited by 103
Emerging Role of Epigenetic Mechanisms in Alcohol Addiction
Berkel, T. D. M., & Pandey, S. C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13338 · Cited by 102
Histone deacetylase inhibitors selectively suppress expression of HDAC7
Dokmanovic, M., Perez, G., Xu, W., Ngo, L., Clarke, C., Parmigiani, R. B., & Marks, P. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0251 · Cited by 99
Histone deacetylase inhibitors – a new tool to treat cancer
Somech, R., Izraeli, S., & Simon, A. J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.04.006 · Cited by 100
Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance
Krumm, A., Barckhausen, C., Kücük, P., Tomaszowski, K.-H., Loquai, C., Fahrer, J., Krämer, O. H., Kaina, B., & Roos, W. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2680 · Cited by 91
Self-citation
Epigenetic-Based Therapies in Cancer
Song, S., Han, S., & Bang, Y. (2011) · Drugs · doi:10.2165/11596690-000000000-00000 · Cited by 98
The SIN3A/HDAC Corepressor Complex Functionally Cooperates with NANOG to Promote Pluripotency
Saunders, A., Huang, X., Fidalgo, M., Reimer, M. H., Faiola, F., Ding, J., Sánchez-Priego, C., Guallar, D., Sáenz, C., Li, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.055 · Cited by 92
Glucose depletion activates mmu-miR-466h-5p expression through oxidative stress and inhibition of histone deacetylation
Druz, A., Betenbaugh, M. J., & Shiloach, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks452 · Cited by 97
Epigenetics in Human Melanoma
Howell, P., Liu, S., Ren, S., Behlen, C., Fodstad, Ø., & Riker, A. I. (2009) · Cancer Control · doi:10.1177/107327480901600302 · Cited by 93
Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer
Heers, H. M., Stanislaw, J., Harrelson, J. P., & Lee, M. W. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.057 · Cited by 92
Histone Deacetylase Inhibitors for Cancer Therapy
Kim, T., Bang, Y., & Robertson, K. D. (2006) · Epigenetics · doi:10.4161/epi.1.1.2644 · Cited by 91
Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
Zádori, D., Geisz, A., Vámos, E., Vécsei, L., & Klivènyi, P. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.001 · Cited by 93
Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
Montani, M. S. G., Granato, M., Santoni, C., Porto, P. D., Merendino, N., D’Orazi, G., Faggioni, A., & Cirone, M. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0314-z · Cited by 93
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
Novohradský, V., Zerzánková, L., Štěpánková, J., Vrána, O., Raveendran, R., Gibson, D., Kašpárková, J., & Brabec, V. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.003 · Cited by 91
c-Abl Stabilizes HDAC2 Levels by Tyrosine Phosphorylation Repressing Neuronal Gene Expression in Alzheimer’s Disease
Gonzalez-Zuñiga, M., Contreras, P. S., Estrada, L. D., Chamorro, D., Villagra, A., Zanlungo, S., Seto, E., & Alvarez, A. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.013 · Cited by 91
Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
Walker, T. D., Mitchell, C., Park, M. A., Yacoub, A., Graf, M. R., Rahmani, M., Houghton, P. J., Voelkel‐Johnson, C., Grant, S., & Dent, P. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056523 · Cited by 91
Histone deacetylase inhibitors: Anticancer compounds
Smith, K. T., & Workman, J. L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.008 · Cited by 90
Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor–Mediated Signaling
Biçaku, E., Marchion, D. C., Schmitt, M. L., & Münster, P. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2822 · Cited by 89
Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis
Krämer, O. H., Knauer, S. K., Zimmermann, D., Stauber, R. H., & Heinzel, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210677 · Cited by 87
Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models
Spencer, E. M., Chandler, K. E., Haddley, K., Howard, M. R., Hughes, D. J., Belyaev, N. D., Coulson, J. M., Stewart, J. P., Buckley, N. J., & Kipar, A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.020 · Cited by 88
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
Rottmann, S., & Lüscher, B. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_4 · Cited by 84
Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
Wagner, T., Brand, P., Heinzel, T., & Krämer, O. H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.010 · Cited by 85
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
Schüler, S., Fritsche, P., Diersch, S., Arlt, A., Schmid, R. M., Saur, D., & Schneider, G. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-80 · Cited by 85
Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells
Wulhfard, S., Baldi, L., Hacker, D. L., & Wurm, F. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.05.003 · Cited by 81
Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer
Sun, J. L., Piao, J., Li, N., Yang, Y., Kim, K., & Lin, Z. (2019) · FEBS Journal · doi:10.1111/febs.15122 · Cited by 83
Epigenetic Activation of Silent Biosynthetic Gene Clusters in Endophytic Fungi Using Small Molecular Modifiers
Pillay, L. C., Nekati, L., Makhwitine, J. P., & Ndlovu, S. I. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.815008 · Cited by 82
Targeting AML1/ETO-Histone Deacetylase Repressor Complex: A Novel Mechanism for Valproic Acid-Mediated Gene Expression and Cellular Differentiation in AML1/ETO-Positive Acute Myeloid Leukemia Cells
Liu, S., Klisovic, R. B., Vukosavljevic, T., Yu, J., Paschka, P., Huynh, L., Pang, J., Neviani, P., Liu, Z., Blum, W. G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118406 · Cited by 81
Hippocampal HDAC4 Contributes to Postnatal Fluoxetine-Evoked Depression-Like Behavior
Sarkar, A., Chachra, P., Kennedy, P., Pena, C. J., Desouza, L. A., Nestler, E. J., & Vaidya, V. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.73 · Cited by 79
Combined prenatal and postnatal butyl paraben exposure produces autism-like symptoms in offspring: Comparison with valproic acid autistic model
Ali, E. H. A., & Elgoly, A. H. M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.016 · Cited by 81
Regulation of Acetylation of Histone Deacetylase 2 by p300/CBP-Associated Factor/Histone Deacetylase 5 in the Development of Cardiac Hypertrophy
Eom, G. H., Nam, Y. S., Oh, J. G., Choe, N., Min, H.-K., Yoo, E.-K., Kang, G., Nguyen, V. H., Min, J.-J., Kim, J.-K., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.303429 · Cited by 79
Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteinsPreprint
Xu, Z., Meng, X., Cai, Y., Hong, L., Nagarajan, L., & Brandt, S. J. (2007) · Genes & Development · doi:10.1101/gad.1528507 · Cited by 79
Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells
Lin, C., Lai, H., Lee, H., Lin, W., Chang, C., Chu, T., Lin, Y., Lee, K., & Yu, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00793.x · Cited by 79
Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors
Wada, T., Kikuchi, J., Nishimura, N., Shimizu, R., Kitamura, T., & Furukawa, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042242 · Cited by 81
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model
Whittle, N., Schmuckermair, C., Gunduz‐Cinar, O., Hauschild, M., Ferraguti, F., Holmes, A., & Singewald, N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.001 · Cited by 76
Differential methylation is associated with non-syndromic cleft lip and palate and contributes to penetrance effects
Alvizi, L., Ke, X., Brito, L. A., Seselgyte, R., Moore, G. E., Stanier, P., & Passos‐Bueno, M. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-02721-0 · Cited by 75
Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation
Kaiser, C., & James, S. R. (2004) · BMC Biology · doi:10.1186/1741-7007-2-23 · Cited by 74
Histone Deacetylases Control Neurogenesis in Embryonic Brain by Inhibition of BMP2/4 Signaling
Shaked-Rabi, M., Weissmueller, K., Svoboda, H., Hortschansky, P., Nishino, N., Wölfl, S., & Tucker, K. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002668 · Cited by 77
Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Coincides with the Loss of Androgen Sensitivity in Hormone Refractory Cancer of the Prostate
Halkidou, K., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2003) · European Urology · doi:10.1016/j.eururo.2003.10.005 · Cited by 74
Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
Kaminskyy, V. O., Surova, O. V., Vaculová, A. H., & Zhivotovsky, B. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr135 · Cited by 73
HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy
Noce, M. L., Paino, F., Mele, L. L., Papaccio, G., Regad, T., Lombardi, A., Papaccio, F., Desiderio, V., & Tirino, V. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0978-x · Cited by 73
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
Caraci, F., Calabrese, F., Molteni, R., Bartova, L., Dold, M., Leggio, G. M., Fabbri, C., Mendlewicz, J., Racagni, G., Kasper, S. F., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014977 · Cited by 76
New anti-cancer strategies: Epigenetic therapies and biomarkers
Balch, C. (2005) · Frontiers in bioscience · doi:10.2741/1668 · Cited by 74
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties
Ximenes, J. C. M., Gonçalves, D. D. O., Siqueira, R. M. P., Neves, K. R. T., Cerqueira, G. S., Correia, A. O., Felix, F. H. C., Leal, L. K. A. M., Brito, G. A. D. C., Naffah‐Mazzacoratti, M. D. G., et al. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0853-4 · Cited by 72
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid
Mora‐García, M. D. L., Dueñas‐González, A., Hernández‐Montes, J., la Cruz-Hernández, E. N. D., Pérez‐Cárdenas, E., Weiss‐Steider, B., Santiago‐Osorio, E., Ortiz-Navarrete, V. F., Rosales, V. H., de León, D. F. C., et al. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-55 · Cited by 72
Mechanism for ubiquitylation of the leukemia fusion proteins AML1‐ETO and PML‐RARα
Krämer, O. H., Müller, S., Buchwald, M., Reichardt, S., & Heinzel, T. (2007) · The FASEB Journal · doi:10.1096/fj.06-8050com · Cited by 72
Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
Mackenzie, G. G., Huang, L., Alston, N., Ouyang, N., Vranková, K., Mattheolabakis, G., Constantinides, P. P., & Rigas, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061532 · Cited by 74
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
Li, Z., Hao, Q., Luo, J., Xiong, J., Zhang, S., Wang, W., Bai, L., Wang, W., Chen, M., Wang, W., et al. (2015) · Oncogene · doi:10.1038/onc.2015.349 · Cited by 73
Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy
Marwick, J. A., Ito, K., Adcock, I. M., & Kirkham, P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.745 · Cited by 71
Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells
Thotala, D. K., Karvas, R. M., Engelbach, J. A., Garbow, J. R., Hallahan, A. N., DeWees, T. A., Laszlo, A., & Hallahan, D. E. (2015) · Oncotarget · doi:10.18632/oncotarget.5253 · Cited by 74
Valproic acid: how it works. Or not
Lagace, D. C., O'Brien, W. T., Gurvich, N., Nachtigal, M. W., & Klein, P. S. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.09.013 · Cited by 72
Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
Mawatari, T., Ninomiya, I., Inokuchi, M., HARADA, S., Hayashi, H., Oyama, K., Makino, I., Nakagawara, H., Miyashita, T., Tajima, H., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3213 · Cited by 69
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes
Belrose, G., Gross, A., Olindo, S., Lézin, A., Dueymes, M., Komla-Soukha, I., Smadja, D., Tanaka, Y., Willems, L., Mesnard, J.-M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321364 · Cited by 69
Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation
Buchwald, M., Pietschmann, K., Müller, J. P., Böhmer, F. D., Heinzel, T., & Krämer, O. H. (2010) · Leukemia · doi:10.1038/leu.2010.114 · Cited by 68
The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Stiborová, M., Eckschlager, T., Poljaková, J., Hraběta, J., Adam, V., Kizek, R., & Frei, E. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712802884286 · Cited by 69
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer
Stauber, R. H., Knauer, S. K., Habtemichael, N., Bier, C., Unruhe, B., Weisheit, S., Spange, S., Nonnenmacher, F., Fetz, V., Ginter, T., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.430 · Cited by 68
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo
Achachi, A., Florins, A., Gillet, N. A., Debacq, C., Urbain, P., Manfouo-Foutsop, G., Vandermeers, F., Jasik, A., Reichert, M., Kerkhofs, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504248102 · Cited by 68
Regulation of Estrogen-Dependent Transcription by the LIM Cofactors CLIM and RLIM in Breast Cancer
Johnsen, S. A., Güngör, C., Prenzel, T., Riethdorf, S., Riethdorf, L., Taniguchi-Ishigaki, N., Rau, T., Tursun, B., Furlow, J. D., Sauter, G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1630 · Cited by 65
Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780
Wu, Y., & Guo, S. (2006) · Gynecologic and Obstetric Investigation · doi:10.1159/000093975 · Cited by 66
Valproic acid induces caspase 3-mediated apoptosis in microglial cells
Dragunow, M., Greenwood, J. M., Cameron, R. E., Narayan, P. J., O’Carroll, S. J., Pearson, A. G., & Gibbons, H. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.065 · Cited by 67
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Korfei, M., Mahavadi, P., & Guenther, A. (2022) · Cells · doi:10.3390/cells11101626 · Cited by 66
Valproic acid inhibits neural progenitor cell death by activation of NF-κB signaling pathway and up-regulation of Bcl-XL
Go, H. S., Seo, J. E., Kim, K. C., Han, S. M., Kim, P., Kang, Y. S., Han, S. H., Shin, C. Y., & Ko, K. H. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-48 · Cited by 67
New perspectives of valproic acid in clinical practice
Činčárová, L., Zdráhal, Z., & Fajkus, J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.853037 · Cited by 64
Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts
Park, J.-J., Kim, Y.-E., Pham, H. T., Kim, E. T., Chung, Y., & Ahn, J. (2007) · Journal of General Virology · doi:10.1099/vir.0.83171-0 · Cited by 64
In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor
Neri, P., Tagliaferri, P., Martino, M. T. D., Calimeri, T., Amodio, N., Bulotta, A., Ventura, M., Eramo, O., Viscomi, C., Arbitrio, M., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07387.x · Cited by 65
Recent advances in inducing endophytic fungal specialized metabolites using small molecule elicitors including epigenetic modifiers
Toghueo, R. M. K., Sahal, D., & Boyom, F. F. (2020) · Phytochemistry · doi:10.1016/j.phytochem.2020.112338 · Cited by 62
Could valproic acid be an effective anticancer agent? The evidence so far
Brodie, S. A., & Brandes, J. C. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.940329 · Cited by 62
Histone deacetylase inhibitors in cancer therapy. A review
Hraběta, J., Stiborová, M., Adam, V., Kizek, R., & Eckschlager, T. (2013) · Biomedical Papers · doi:10.5507/bp.2013.085 · Cited by 64
Deacetylase inhibitors - focus on non-histone targets and effects
Ocker, M. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i5.55 · Cited by 61
Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5
Griffin, E. A., Melas, P. A., Zhou, R. W., Li, Y., Mercado, P., Kempadoo, K. A., Stephenson, S. I., Colnaghi, L., Taylor, K. M., Hu, M., et al. (2017) · Science Advances · doi:10.1126/sciadv.1701682 · Cited by 63
MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism
Kim, K. C., Choi, C. S., Kim, J.-W., Han, S.-H., Cheong, J. H., Ryu, J. H., & Shin, C. Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-8987-z · Cited by 60
Valproic Acid Promotes Human Glioma U87 Cells Apoptosis and Inhibits Glycogen Synthase Kinase-3β Through ERK/Akt Signaling
Zhang, C., Liu, S., Yuan, X., Hu, Z., Li, H., Wu, M., Yuan, J., Zhao, Z., Su, J., Wang, X., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447912 · Cited by 60
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia
Mims, A. S., Walker, A. R., Huang, X., Sun, J., Wang, H., Santhanam, R., Dorrance, A. M., Walker, C. J., Hoellerbauer, P., Tarighat, S. S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.342 · Cited by 60
HDAC2 regulates chromatin plasticity and enhances DNA vulnerability
Marchion, D. C., Biçaku, E., Turner, J. G., Schmitt, M. L., Morelli, D., & Münster, P. N. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0985 · Cited by 62
Sex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder
Jeon, S. J., Gonzales, E. L., Mabunga, D. F. N., Valencia, S. T., Kim, D. G., Kim, Y., Adil, K. J., Shin, D., Park, D., & Shin, C. Y. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.321 · Cited by 67
Histone Deacetylase Classes I and II Regulate Kaposi's Sarcoma-Associated Herpesvirus Reactivation
Shin, H. J., DeCotiis, J., Giron, M., Palmeri, D., & Lukac, D. M. (2013) · Journal of Virology · doi:10.1128/jvi.02665-13 · Cited by 63
Molecular mechanisms of psychiatric diseases
Blokhin, I. O., Khorkova, O., Saveanu, R. V., & Wahlestedt, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105136 · Cited by 64
Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors
Sacco, J. J., Kenyani, J., Butt, Z., Carter, R., Chew, H. Y., Cheeseman, L. P., Darling, S., Denny, M., Urbé, S., Clague, M. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3765 · Cited by 63
Small Chemical Chromatin Effectors Alter Secondary Metabolite Production in Aspergillus clavatus
Zutz, C., Gacek‐Matthews, A., Sulyok, M., Wagner, M., Strauss, J., & Rychli, K. (2013) · Toxins · doi:10.3390/toxins5101723 · Cited by 59
Epigenetic Regulation of Neuroinflammation in Alzheimer’s Disease
Ma, Y., Wang, W., Liu, S., Qiao, X., Xing, Y., Zhou, Q., & Zhang, Z. (2023) · Cells · doi:10.3390/cells13010079 · Cited by 58
Combined exposure of lead and cadmium leads to the aggravated neurotoxicity through regulating the expression of histone deacetylase 2
Zhou, R., Zhao, J., Li, D., Chen, Y., Xiao, Y., Fan, A., Chen, X.-T., & Wang, H.-L. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126589 · Cited by 56
HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
Hackanson, B. W., Rimmele, D. L., Benkißer-Petersen, M., Abdelkarim, M., Fliegauf, M., Jung, M., & Lübbert, M. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.02.026 · Cited by 56
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
Zárate-López, D., Torres-Chávez, A. L., Gálvez‐Contreras, A. Y., & González-Pérez, Ó. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231003121513 · Cited by 62
Regulation of histone modifying enzymes by the ubiquitin–proteasome system
Zou, C., & Mallampalli, R. K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.12.016 · Cited by 53
Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1)
Chen, W., Weng, J., Huang, C. J., & Chung, B. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00476-07 · Cited by 57

Authors: Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., & Göttlicher, M.
Affiliations: Georg Speyer Haus (DE)
Universität Hamburg (DE)
Corresponding author: Heinzel, Thorsten
Göttlicher, Martin
ORCID: Krämer, Oliver H.
Golebiewski, Martin
Bach, Ingolf
Heinzel, Thorsten
Göttlicher, Martin
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 2003-07-01
Volume: 22
Issue: 13
Pages: 3411-3420
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1093/emboj/cdg315
PMC: PMC165640
OpenAlex: W2106775330
Cited by: 523
References: 41
Citations by year: 2026: 5 · 2025: 8 · 2024: 14 · 2023: 13 · 2022: 25 · 2021: 16 · 2020: 19 · 2019: 20 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 19 · 2014: 27 · 2013: 33 · 2012: 29
FWCI: 8.96
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Site cant be reached (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: valproic acid, HDAC2, histone deacetylase inhibitors, proteasomal degradation, ubiquitin-proteasome system, RLIM, polyubiquitination, trichostatin A, class I HDACs, protein turnover
MeSH terms: Animals, Base Sequence, Cells, Cultured, Cysteine Endopeptidases, Enzyme Inhibitors, Female, Hydrolysis, Hydroxamic Acids, Multienzyme Complexes, Valproic Acid, DNA Primers, Ubiquitin, Proteasome Endopeptidase Complex, Mice, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks